GMDC bestows top honor to longtime Unilever exec
ORLANDO, Fla. — The Global Market Development Center has awarded Jerry Brown its 2012 Lifetime Achievement Award. The honor was given on June 3 during the "Dinner with the Chairman" at the 42nd Annual 2012 General Merchandise Conference in Orlando, Fla.
The GMDC Lifetime Achievement Award was initiated in 1995, during the 25th anniversary of the association, to honor individuals who have been industry leaders and made significant contributions to the general merchandise and health beauty wellness categories during their careers. The Lifetime Achievement Award recipient is recognized primarily for contributions to the industry as a whole, but also for his or her contributions to their own company and GMDC. The selection of the annual recipient is made by a special committee comprised of past GMDC chairmen of the board who are still active in the Association and the GMDC executive committee.
Jerry Brown began his business career with Johnson & Johnson Baby Products. In 1980, he began a career with Chesebrough’s — Pond, Ragu Packaged Foods Division. He held numerous field and internal positions in three of Chesebrough’s (now Unilever) Division — Ragu (Foods), Chesebrough Health and Beauty, and Prince Matchabelli (Cosmetics and Fragrances).
In 1996, he assumed a position in the industry and customer development department with Unilever. He was promoted to VP industry and customer development for Unilever home and personal care in 1998. Jerry ended his tenure in December 2011 leading Unilever’s industry and customer development team. Jerry is currently serving on numerous industry committees and on the advisory boards including: GMDC, NACDS, RILA, FMI, CIES, NGA, IGA, SIFE, and BEEP. Brown also served as GMDC HBW advisory board chairman, membership advisory board chairman, and was a longtime director of the Education Leadership Council.
"Jerry has been an incredible contributor to GMDC and our industry for decades," GMDC president and CEO Dave McConnell said. "His recognition this evening is not only well deserved … it is an incredibly popular selection amongst his peers and partners."
You will be receiving hundreds of notes of praise to Jerry and his well deserved award in recognition of his business insights, dedication to his company and standard of excellence. I praise his wonderful sense of humor, moral center and his daily reminder that good indeed triumphs. To Jerry, a true gentleman and mentsch and Glenna his love and support the very best. Terry Augenbraun
WAG, ESI mutually dismiss legal proceedings; WAG extends agreement with PBM OptumRx
DEERFIELD, Ill. — Walgreens on Monday confirmed its legal dispute with Express Scripts has been mutually dropped in what many analysts are heralding as the beginning of the end of the Walgreens-Express Scripts dispute of 2012.
“The parties have agreed to dismiss their respective claims, and no other action has been or will be taken by either party with respect to this case," Walgreens said. "These dismissals have no impact on the parties’ ability or inability to come to terms on a pharmacy agreement. The parties and their counsel will have no further comment on this matter.”
In separate-yet-related news, Walgreens announced the extension of a multiyear agreement with OptumRx, one of the largest pharmacy benefit managers in the United States. “We help drive down total healthcare costs through our industry-leading generic dispensing and conversion rates and our broad range of additional clinical services and advice that help improve patient care and health outcomes. We are pleased that OptumRx recognizes the service and value we bring to its clients," the pharmacy retailer stated in a separate release issued Monday morning.
“Walgreens offers both the pharmacy and overall health care value sought by PBMs like OptumRx who are developing differentiated member services and benefits for their clients,” added Kermit Crawford, Walgreens president of pharmacy, health and wellness. “We help drive down total health care costs through our industry-leading generic dispensing and conversion rates and our broad range of additional clinical services and advice that help improve patient care and health outcomes. We are pleased that OptumRx recognizes the service and value we bring to its clients.”
I totally support WAG's actions and integratity to stand on business principles and fight back trends from PBMs, Medicaid, and other payers which they believe are contrary to its long term growth and profitability. Only WAG consistantly has shown this business virture across a long history of business cycles up and downs. Their competitors have not done the same, and actually been more opportunists in picking up the short term business loss ... and not realizing that they are splitting their industry segment strengths and underminding their long term health. WAG's has taken a short term 30% HIT in valuation ... demononstrating their commitment. My hat is OFF to you, I'd work for this kind of company anytime. Robert Chan Managing Partner Health Resource Management, Inc
Hi-Tech Pharmacal completes acquisition of dermatosis treatment
AMITYVILLE, N.Y. — Hi-Tech Pharmacal has acquired rights to a topical drug for treating dermatoses of the scalp from Watson, Hi-Tech said Monday.
Hi-Tech announced the acquisition of Cormax (clobetasol propionate) topical solution for an undisclosed sum. The drug had sales of about $600,000 in 2011, according to IMS Health. The drug maker acquired the drug through its ECR Pharmaceuticals subsidiary and plans to launch it this month.
"Since Hi-Tech will manufacture Cormax for our ECR subsidiary, we anticipate the product will generate high margins," Hi-Tech president and CEO David Seltzer said. "We are pleased to add another well-recognized brand to the ECR portfolio of branded products."
No comments found